BBHC
GILD icon

Brown Brothers Harriman & Co’s Gilead Sciences GILD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Sell
18,962
-532
-3% -$70.1K 0.01% 328
2026
Q1 		$2.72M Buy
19,494
+9,540
+96% +$1.34M 0.01% 267
2025
Q4 		$1.22M Buy
9,954
+5,162
+108% +$627K 0.01% 340
2025
Q3 		$532K Buy
4,792
+2,078
+77% +$236K ﹤0.01% 466
2025
Q2 		$301K Buy
2,714
+1,818
+203% +$193K ﹤0.01% 556
2025
Q1 		$100K Buy
896
+166
+23% +$17.1K ﹤0.01% 699
2024
Q4 		$67.4K Sell
730
-110
-13% -$9.9K ﹤0.01% 818
2024
Q3 		$70.4K Sell
840
-506
-38% -$38.6K ﹤0.01% 749
2024
Q2 		$92.3K Sell
1,346
-364
-21% -$24.3K ﹤0.01% 672
2024
Q1 		$125K Buy
1,710
+720
+73% +$55.4K ﹤0.01% 609
2023
Q4 		$80.2K Sell
990
-172
-15% -$13.4K ﹤0.01% 655
2023
Q3 		$87.1K Buy
1,162
+568
+96% +$43.7K ﹤0.01% 624
2023
Q2 		$45.8K Sell
594
-24
-4% -$1.91K ﹤0.01% 727
2023
Q1 		$51.3K Sell
618
-127
-17% -$10.5K ﹤0.01% 734
2022
Q4 		$64K Sell
745
-825
-53% -$65.3K ﹤0.01% 675
2022
Q3 		$97K Sell
1,570
-200
-11% -$12.6K ﹤0.01% 595
2022
Q2 		$109K Buy
1,770
+195
+12% +$12.1K ﹤0.01% 563
2022
Q1 		$94K Sell
1,575
-631
-29% -$40.3K ﹤0.01% 642
2021
Q4 		$160K Buy
2,206
+19
+0.9% +$1.31K ﹤0.01% 522
2021
Q3 		$153K Sell
2,187
-789
-27% -$55.4K ﹤0.01% 498
2021
Q2 		$205K Sell
2,976
-462
-13% -$30.8K ﹤0.01% 432
2021
Q1 		$222K Sell
3,438
-3,618
-51% -$233K ﹤0.01% 397
2020
Q4 		$411K Buy
7,056
+161
+2% +$9.71K ﹤0.01% 330
2020
Q3 		$436K Sell
6,895
-1,066
-13% -$73.9K ﹤0.01% 282
2020
Q2 		$613K Buy
7,961
+1,172
+17% +$89.8K ﹤0.01% 236
2020
Q1 		$508K Sell
6,789
-3,859
-36% -$267K ﹤0.01% 248
2019
Q4 		$692K Sell
10,648
-1,852
-15% -$121K ﹤0.01% 266
2019
Q3 		$792K Buy
12,500
+3,206
+34% +$210K 0.01% 248
2019
Q2 		$628K Sell
9,294
-1,139
-11% -$74.9K ﹤0.01% 253
2019
Q1 		$678K Buy
10,433
+7,681
+279% +$511K ﹤0.01% 232
2018
Q4 		$172K Sell
2,752
-12,962
-82% -$906K ﹤0.01% 365
2018
Q3 		$1.21M Sell
15,714
-1,199
-7% -$90.6K 0.01% 183
2018
Q2 		$1.2M Buy
16,913
+1,362
+9% +$96.2K 0.01% 172
2018
Q1 		$1.17M Buy
15,551
+13,453
+641% +$1.07M 0.01% 169
2017
Q4 		$150K Buy
2,098
+1,790
+581% +$136K ﹤0.01% 384
2017
Q3 		$25K Sell
308
-255
-45% -$19.5K ﹤0.01% 565
2017
Q2 		$40K Sell
563
-50
-8% -$3.33K ﹤0.01% 507
2017
Q1 		$42K Sell
613
-4,504
-88% -$317K ﹤0.01% 507
2016
Q4 		$366K Hold
5,117
– – ﹤0.01% 241
2016
Q3 		$405K Buy
5,117
+46
+0.9% +$3.74K ﹤0.01% 240
2016
Q2 		$423K Sell
5,071
-126
-2% -$11.2K ﹤0.01% 244
2016
Q1 		$477K Buy
5,197
+1,000
+24% +$90.2K ﹤0.01% 232
2015
Q4 		$425K Sell
4,197
-450
-10% -$46.8K ﹤0.01% 250
2015
Q3 		$456K Buy
4,647
+523
+13% +$58.1K ﹤0.01% 247
2015
Q2 		$483K Buy
4,124
+389
+10% +$42.5K ﹤0.01% 253
2015
Q1 		$367K Sell
3,735
-837
-18% -$85K ﹤0.01% 290
2014
Q4 		$431K Sell
4,572
-320
-7% -$33.1K ﹤0.01% 276
2014
Q3 		$521K Buy
4,892
+471
+11% +$46.1K ﹤0.01% 254
2014
Q2 		$367K Sell
4,421
-1,175
-21% -$91.5K ﹤0.01% 294
2014
Q1 		$397K Sell
5,596
-19,204
-77% -$1.51M ﹤0.01% 266
2013
Q4 		$1.86M Buy
24,800
+18,004
+265% +$1.25M ﹤0.01% 188
2013
Q3 		$427K Buy
6,796
+3,550
+109% +$212K ﹤0.01% 257
2013
Q2 		$166K Buy
+3,246
New +$169K ﹤0.01% 398

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Brothers Harriman & Co's GILD Position: Q2 2026 in Review

Brown Brothers Harriman & Co reduced its Gilead Sciences (GILD) stake by 2.7% in Q2 2026, selling an estimated $70.1K and leaving 18,962 shares worth $2.4M. The position accounts for 0.01% of the portfolio, ranked #328.

Brown Brothers Harriman & Co first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.72M in Q1 2026. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Brown Brothers Harriman & Co held 18,962 shares of Gilead Sciences worth $2.4M as of Q2 2026.
  • Brown Brothers Harriman & Co sold 532 Gilead Sciences shares in Q2 2026, an estimated $70.1K.
  • Gilead Sciences made up 0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #328 holding.
  • Brown Brothers Harriman & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Brown Brothers Harriman & Co's Gilead Sciences position peaked at $2.72M in Q1 2026.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.